News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
150 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17680)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
IMPACT Therapeutics Raises $30 Million In Series C Financing
IMPACT Therapeutics, Inc. (IMPACT) today announced the completion of $30 million in series C financing.
August 3, 2018
·
3 min read
Business
Innovus Pharmaceuticals to Release Its Second Quarter 2018 Financial Results on Tuesday, August 14, 2018
Innovus Pharmaceuticals, Inc. announced that the Company will release its June 30, 2018 second quarter financial results on Tuesday, August 14, 2018, after the close of the U.S. financial markets.
August 3, 2018
·
3 min read
Drug Development
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Parkinson’s Disease (PD) Patients Whose Symptoms are Uncontrolled With Oral Medication
Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet Neurology[1].
August 3, 2018
·
2 min read
Business
Lannett Enters Licensing Agreement For Generic Concerta®, Methylphenidate Hydrochloride ER Tablets
Lannett Company, Inc. announced that it has entered into an exclusive perpetual licensing agreement with Andor Pharmaceuticals, LLC for Methylphenidate Hydrochloride Extended Release (ER) tablets USP (CII) in 18 mg, 27 mg, 36 mg and 54 mg strengths.
August 3, 2018
·
2 min read
Business
Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and Syed Jafry to Board of Directors
ZHilado and Jafry Bring Financial Acumen and Global Experience to Board of Directors
August 3, 2018
·
3 min read
Deals
Peloton Announces $550M In Series F Funding Led By TCV
Funding Round Will Bolster Fitness Company’s International Expansion, Product Innovation and Retail Footprint
August 3, 2018
·
4 min read
Business
Omeros Corporation to Announce Second Quarter 2018 Financial Results on August 9, 2018
Omeros Corporation announced that the company will issue its second quarter 2018 financial results for the period ended June 30, 2018, on Thursday, August 9, 2018, after the market closes.
August 3, 2018
·
2 min read
Genetown
bluebird bio to Present at the 2018 Wedbush PacGrow Healthcare Conference
bluebird bio, Inc. announced that members of the management team will present at the 2018 Wedbush PacGrow Healthcare Conference, Tuesday, August 14, at 8:35 a.m. ET at the Parker New York Hotel, New York City.
August 3, 2018
·
3 min read
Business
Salix Expands Microbiome Research And Discovery Through Strategic Collaboration With Cedars-Sinai Medical Center
Research Led by Dr. Mark Pimentel’s Lab Will Explore the Role of the Microbiome in the Treatment of Gastrointestinal (GI) Disorders
August 3, 2018
·
5 min read
CMS Grants New Technology Add-On Payment to Vyxeos® (daunorubicin and cytarabine) Liposome for Injection
Jazz Pharmaceuticals plc announced that the United States Centers for Medicare and Medicaid Services (CMS) granted approval for a New Technology Add-on Payment (NTAP) for Vyxeos® (daunorubicin and cytarabine) liposome for injection for the treatment of adults with newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC), a rapidly progressing and life-threatening blood cancer.
August 3, 2018
·
9 min read
Previous
11 of 15
Next